DoD Amyotrophic Lateral Sclerosis, Clinical Development Award
The intent of the FY21 ALSRP Clinical Development Award is to support correlative studies leveraging human-based ALS resources to enrich clinical trials or to optimize components of current ALS clinical care. Leveraging can refer to the use of existing well-characterized and highly curated resources or collaboration with ongoing clinical research to amplify potential gains in knowledge. Analysis of results and/or biosamples collected under these projects should be made broadly available through deposition in existing publicly available curated repositories and data platforms. Clinical intervention studies do not meet the intent of this funding opportunity. Investigators interested in intervention clinical trials should consider applying under the FY21 ALSRP Therapeutic/Biomarker Trial Pilot Award (Funding Opportunity Number: W81XWH-21- ALSRP-TBPTA). For information about these award mechanisms, see https://cdmrp.army.mil/funding/alsrp. Use of existing well-characterized and highly c...